Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells. by Hettinga, J. V. et al.
British JournalofCancer(1997) 75(12), 1735-1743
© 1997 Cancer Research Campaign
Mechanism of hyperthermic potentiation of cisplatin
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Summary In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDDP) sensitivity in cDDP-
sensitive and -resistant cell lines of murine as well as human origin were investigated. Heating cells at 430C during cDDP exposure was found
to increase drug accumulation significantly in the cDDP-resistant cell lines but had little effect on drug accumulation in the cDDP-sensitive cell
lines. DNA adduct formation, however, was significantly increased in all cell lines studied. Furthermore, ongoing formation of platinum
(Pt)-DNA adducts afterthe end ofcDDP treatment was enhanced and/or adduct removal was decreased in heated cells, resulting in relatively
more DNA damage remaining at 24 h after the end of cDDP exposure. Correlation plots with survival revealed weak correlations with cellular
Pt accumulation (r2 = 0.59) and initial Pt-DNA adduct formation (r2 = 0.64). Strong correlations, however, were found with Pt-DNA adducts
at 6 h (r2 = 0.97) and 24 h (r2 = 0.89) afterthe incubation with the drug. In conclusion, the mechanism by which heat sensitizes cells for cDDP
action seems to be the sum of multiple factors, which comprise heat effects on accumulation, adduct formation and adduct processing. This
mechanism did not seem to differ between cDDP-sensitive and -resistant cells, emphasizing the potential of hyperthermia to reduce cDDP
resistance.
Keywords: thermochemosensitization; cisplatin resistance; cisplatin accumulation; cisplatin-DNA adducts; adduct repair
Hyperthermia can strongly potentiate the cytotoxic action of cis-
diamminedichloroplatinum (cisplatin, cDDP) both in vitro and in
vivo (reviewed by Engelhardt, 1987). In addition, relatively high
heat doses (above 42°C) can (partly) reverse in vitro acquired
cDDP resistance (Wallner et al, 1986; Herman et al, 1988;
Mansouri et al, 1989; Konings et al, 1993; Hettinga et al, 1994).
Resistance to cDDP is a major problem in the clinic and limits the
success of this drug. Thus, the combined use of heat and cDDP
appears to be an interesting possibility to minimize this problem.
The mechanism by which cells become resistant to cDDP has
been extensively studied by numerous groups and has been found
to be multifactorial (reviewed by Andrews and Howell, 1990),
including (combinations of) decreased drug accumulation,
increased detoxification ofthe drug via glutathione (GSH) metab-
olism or metallothioneins, decreased drug-DNA adduct formation
and increased repair ofthe drug-induced DNA damage. The mech-
anism(s) by which hyperthermia sensitizes cells to cDDP is (are)
less clear. Altered platinum (Pt) accumulation, total Pt-DNA
adduct and DNA cross-link formation and/or repair of DNA
damage have been reported as aresult ofcombined heat and cDDP
treatments (Meyn et al, 1980; Wallner et al, 1986; Herman et al,
1988, 1989, 1990; Mann et al, 1988; Mansouri et al, 1989;
Eichholtz-Wirth and Hietel, 1990; Los et al, 1993; Takahashi et al,
1993; Ohno et al, 1994). However, the published data are rather
contradictory, and in most papers only some of the above-
mentioned parameters were studied. Moreover, the mechanism of
hyperthermic cDDP sensitization in cDDP-resistant cells has not
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been investigated before. We therefore performed a comprehen-
sive study on all these parameters in cDDP-sensitive and -resistant
murine and human tumour cell lines after cDDP treatment at 37°C
andhyperthermic temperatures to investigaterelevantmechanisms
ofcDDP resistance and hyperthermic chemosensitization.
MATERIALS AND METHODS
Materials
The cDDP was obtained from Aldrich (Milwaukee, WI, USA).
Stock solutions of 1000 jig ml-' in water were stored in 1-ml
portions at -80°C for no longer than 1 month. Roswell Park
Memorial Institute (RPMI) 1640 medium, fetal calf serum and
newborn calf serum for the soft agar plates were purchased from
Gibco (Paisley, UK). Bovine calf serum for clonogenic survival
assay ofthe human cell lines was obtained from Hyclone (Logan,
UT, USA). Hoechst 33258 was from Calbiochem (La Jolla,
CA, USA), fluorescein isothiocyanate (FITC)-conjugated swine
anti-rabbit antibody from Dakopatts (Glostrup, Denmark) and
Immunofluor mounting medium from ICN Biomedicals (Costa
Mesa, CA, USA). Bovine serum albumin was provided by CLB
(Amsterdam, The Netherlands) and human AB serum by the
Blood Bank Groningen-Drenthe (Groningen, The Netherlands).
All other standard chemicals were obtained from Sigma (St Louis,
MO, USA) or Merck (Darmstadt, Germany).
Cell lines
Two cloned Ehrlich Ascites tumour murine cell lines were used: a
cDDP-sensitive EN line (cloned without prior exposure to cDDP)
and a cDDP-resistant ER line (cloned after treatment with cDDP)
(Konings et al, 1993).
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In addition, two human small-cell lung carcinoma cell lines
(GLC4 and its subline with in vitro acquired resistance to cDDP,
GLC4-cDDP) were used. The GLC4 and (other) cDDP-resistant
sublines have been described before (Hospers et al, 1988, 1990;
Meijer et al, 1990). The GLC4-cDDP cells used in the study
presented here were exposed once monthly to 75 gg ml-' cDDP
36 times (about 3 years). A large batch of cells from this cDDP
passage was stored in liquid nitrogen and these cells were used for
all experiments. Cells were cultured for no longer than 6 weeks,
after which fresh cells were thawed from liquid nitrogen storage.
All cells were grown in suspension culture in RPMI-1640
medium supplemented with 10% fetal calfserum, 100 U ml-' peni-
cillin and 100 jig ml-' streptomycin. The doubling time of both
murine cell lines was 11 h, and the doubling times of GLC4 and
GLC4-cDDP cells were 16 and 22 h respectively.
Conditions for hyperthermia and for incubaticns with
cDDP
For cDDP treatment, the cDDP stock solution was thawed to room
temperature immediately before each experiment and diluted in
complete medium. The cDDP was added 10 or 20 times concen-
trated to the cell suspension (final cell concentration 1 x 106 ml-1).
The incubation (1.5 h) was performed under continuous gentle
shaking. For the combined treatments ofhyperthermia and cDDP,
the hyperthermia was administered during the first part of the
incubation period with cDDP, after which the remaining incuba-
tion was performed at 37°C. For studies measuring Pt-DNA
adducts using the immunocytochemical detection method, the
cells were incubated with cDDP for 4 h to allow for substantial
bifunctional adduct formation (see below). Again, hyperthermia
was given during the first part of the incubation with cDDP.
Hyperthermia was performed in precision waterbaths (± 0.05°C).
Determination of cell survival
For clonogenic survival determination, the samples were washed
after treatment in complete medium, appropriately diluted to
obtain about 100 colonies per plate and plated on 0.5% soft agar
plates as described previously (Konings et al, 1993; Hettinga et al,
1994). In the absence of treatment, plating efficiencies were
always over 90% for the EN and ER cells and about 50-70% for
the GLC4 and GLC4-cDDP cells.
Determination of cellular platinum accumulation and
platinum-DNA adduct formation
To measure cellular Pt accumulation and Pt-DNA adduct forma-
tion, 50 x 106 cells were treated with cDDP in a total volume of
50 ml of medium as described above. After incubation, the cells
were either washed at room temperature with medium and placed
back at 37°C to study DNA adduct formation and removal as a
function oftime after the end of incubation or processed immedi-
ately for cDDP accumulation and initial adduct formation. The
cells were pelleted (at 4°C) and washed three times with 10 ml of
ice-cold phosphate-buffered saline (PBS).
Approximately 5 x 106 cells (1 ml ofthe cell suspension in PBS)
were used to measure total cellular cDDP content. The pellets
were dried overnight at 70°C, after which the dry weight of the
samples was determined. The amount ofplatinum was determined
with a model 1275 flameless atomic absorption spectrophotometer
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Figure 1 Thermal enhancement of cDDP sensitivity of EN and ER cells.
Clonogenic survival curves of EN and ER cells treated with cDDP for 1.5 h at
370C or combined with 30 or 60 min 430C heat treatment. The cDDP survival
curves were corrected for heat-induced cell killing (30 min at 430C,
survival: EN 48.4% ± 3.6 and ER 91.4% ± 3.8; 60 min at 430C, survival:
EN 5.36% ± 1.54 and ER 20.3% ± 5.6). Data shown are the mean of three
to six independent experiments. Bars (s.e.m.) are shown when they
exceed the symbol
(FAAS) with Zeeman background correction, equipped with a
model GTA-95 graphite tube atomizer and an autosampler (Varian
Techtron Pty, Mulgrave, Victoria, Australia). The Pt accumulation
was expressed as jig ofPt per g (dry weight) ofcells.
The remaining 9 ml of cell suspension (approximately 45 x 106
cells) was used to determine the total amount ofplatinum bound to
the DNA. DNA was isolated according to the method described by
Fichtinger-Schepman et al (1987). Briefly, the cell pellets were
resuspended in a 10 mm Tris-HCl/lmm sodium EDTA buffer
with 0.1 M ammonium hydrocarbonate. The cells were lysed with
sodium dodecyl sulphate (final concentration 1% w/v) and treated
overnight with proteinase K (250 jig ml-'). The samples were
extracted twice with phenol-chloroform-isoamylalcohol (25:24:1),
followed by ethanol precipitation of the DNA. After a subsequent
RNAase treatment (75 jig ml-' RNAase A and 75 U ml-' RNAase
TI for 2 h at 37°C), remaining proteins were extracted by chloro-
form-isoamyl alcohol (24:1), and the DNA was precipitated again
with ethanol. The isolated DNA was freeze dried. The amount of
Pt was measured by FAAS as above and related to the amount of
DNA in the samples, as measured byOD26,,nm.
For the repair studies, replication of DNA during the repair
period was checked using measurement of dilution of label in the
DNA of [3H]thymidine prelabelled cells as described previously
(Meijer et al, 1990) and, when necessary, Pt-DNA adduct levels
were corrected for this dilution factor. Cellular integrity, measured
by trypan blue exclusion, was unaffected for up to 24 h after an
incubation of cells with 25 jg ml-' cDDP (given both with or
without heat treatment).
Immunocytochemical detection of Pt-DNA adducts
GPt, a polyclonal antibody against platinated DNA which detects
the main Pt-containing intrastrand cross-links (the Pt-GG adducts)
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Figure 3 Thermal enhancement of cDDP sensitivity of GLC4 and GLC4-
cDDP cells. Clonogenic survival curves of GLC4 and GLC4-cDDP cells
treated with cDDP for 1.5 h at 370C or combined with 30 or 60 min 430C heat
treatment. The CDDP survival curves were corrected for heat-induced cell
killing (30 min at 430C, survival: GLC4 38.4% ± 6.1 and GLC4-cDDP
30.0% ± 1.7; 60 min at 430C, survival: GLC4 5.04% ± 0.87 and GLC4-cDDP
7.40% ± 2.45). Data shown are the mean of 3 or 4 independent experiments.
Bars (s.e.m.) are shown when they exceed the symbol
and the interstrand cross-links, was used for immunocytochemical
detection of Pt-DNA adducts in the GLC4 and GLC4-cDDP cells
(Meijer et al, 1995). After treatment and subsequent washing,
cytospin slides were prepared, air dried, fixed in cold (-20°C)
methanol for 10 min followed by cold (-20°C) acetone for 2 min,
air dried again and stored at -20'C until immunostaining. Upon
staining, the slides were dried, washed with PBS and treated for
30 min with 1% human AB serum and 1% bovine serum albumin
to block non-specific antibody binding, followed by an ovemight
treatment with GPt (1:6) at room temperature. After washing with
PBS, the presence ofplatinated DNA was visualized by incubation
with a FITC-conjugated swine anti-rabbit antibody and counter-
stained for DNA detection by Hoechst. An antifade mounting
medium was applied and slides were stored at4°C in the dark until
image analysis. Double-fluorescence microscopy image analysis
was used to quantify DNA platination. Hoechst fluorescence was
used for identification ofthe nuclear area, and FITC fluorescence,
expressed as median FITC surface fluorescence ofthe nuclei, was
measured. At least 100 nuclei per slide were analysed.
Statistical analysis
To analyse the effects ofhyperthermia on cellular Pt accumulation
and Pt-DNA adduct formation, the accumulation/adduct data were
expressed relative to those in unheated cells in each individual
experiment at each cDDP concentration. Subsequently, the
average relative effect of heat was calculated within the separate
experiments, irrespective ofthe concentration used. For all experi-
ments, weighed average effects and standard errors of the mean
were calculated and used to test for significance using the
Student's t-test. This method was also used to test for differences
between cDDP-sensitive and -resistant cell lines. The average
relative effect of heating for the individual cDDP concentrations
was calculated and tested for significance as well. In addition to
testing the relative effects of heat using the Student's t-test, the
distribution-free sign test was used. This test gives only informa-
tion on whether heat has an effect on the parameters studied
without giving data on the extent of this effect. P < 0.05 was
considered to be statistically significant.
RESULTS
Thermochemosensitization of EN and ER cells
Figure 1 shows cDDP survival curves ofEN and ER cells at 37'C
incubation as well as for combined treatments with 30 or 60 min at
43°C. The cDDP survival curves were corrected for heat-induced
cell killing. The ER cells were also somewhat cross-resistant to
hyperthermia [30 min at 43°C, survival: EN 48.4% and ER 91.4%
(P < 0.005); 60 min at 43°C, survival: EN 5.36% and ER 20.3%
(P < 0.005)]. Both sensitive and resistant cells can be sensitized
to a great extent by the heat treatment. Thermal enhancement
ratios at the 10% survival level (TERs) were, for the EN cells,
4.22 ± 0.43 and 6.28 ± 0.54 for 30 min and 60 min at 43°C
respectively (mean ± s.e.m.). Forthe ERcells, TERs of3.36± 0.11
and 5.61 ± 0.52 were found (mean ± s.e.m.). Hence, despite the
slight difference in heat sensitivity, sensitization to cDDP by
43°C heat was similar in both cell lines.
Comparison of Pt accumulation and Pt-DNA adduct
formation in EN and ER cells (370C)
Figure 2A and B shows the cellular Pt accumulation in EN and ER
cells respectively. When the cells are treated at 37°C, the ER cells
accumulated about three times less drug than the EN cells
(P < 0.0005). The decreased drug accumulation was accompanied
by a lowered Pt-DNA adduct formation (Figure 2C and D). The
Pt-DNA levels were approximately threefold lowerin the resistant
cells (P < 0.0005). Pt-DNA adducts were also measured 6 and
24 h afterthe end ofthe drug exposure and were expressed relative
to immediately after incubation (Figure 2E). About 30-4Q% ofthe
adducts were removed during this time period without a signifi-
cant difference between the two cell lines.
Heat (430C) effects on Pt accumulation and Pt-DNA
adduct formation in EN and ER cells
Figure 2 shows the effect of heat on cellular Pt accumulation and
Pt-DNA adduct formation in EN and ER cells. Heat affected the
accumulation of cDDP in EN cells only slightly (Figure 2A).
Although performing a sign test on paired samples indicated a
significant effectofbothheattreatments (P < 0.005), it is clearthat
the extent ofthe enhancement was rather small (factor of 1.22 and
1.38 for 30 and 60 min at 43°C respectively). In the resistant ER
cells, on the otherhand, heat did have a more pronouncedeffect on
Pt accumulation (Figure 2B). Statistical analysis revealed thermal
enhancement of accumulation by factors of 1.49 and 1.85 respec-
tively (30 and 60 min at 43°C, P < 0.0005).
Total Pt-DNA adduct formation was significantly enhanced
(P < 0.0005) immediately after 30- and 60-min heat treatments in
both EN (1.7-fold) and ER cells (2.5-fold) (Figure 2C and D). At
the 6-h timepoint after cDDP removal, relative Pt-DNA adduct
levels in the 30-min-heated cells did not differ from the unheated
situation in both cell lines. However, the fraction of adducts
remaining in the 60-min-heated EN cells was significantly
elevated compared with unheated cells (Figure 2E, P < 0.005). At
British Journal ofCancer (1997) 75(12), 1735-1743 0 CancerResearch Campaign 1997Mechanism ofinteraction between heatandcDDP 1739
A
a
a)
IC (l
140
120
100
80
60
40
20
60 min at43aC
30 min at430C
037°C
[cDDP] (,Lg mr')
60min'at43CC
< 400- ~~~~~~~~~30 min at430C
,,50S. . . .... . .._
-037CC
10
O0 25 50 25 50
[cDDP] (ggmri)
C
1.f; uD~~GG4-cDDP..
( .5
X _ t > ~~~~~~~~~~60 min at 43°C|
co z
0 6 24 0 6 24
Hours afterend ofcDDP incubation
Figure 4 Drug accumulation and Pt-DNA adduct formation in GLC4 and
GLC4-cDDP cells treated with cDDP alone or combined with 430C heat. Pt
accumulation (A; n = 2-7) and Pt-DNA adduct formation (B; n = 3-6) in
GLC4 and GLC4-cDDP cells after treatment with a cDDP concentration of 25
or 50 ,ug ml-', and Pt-DNA adducts 6 and 24 h after the end of a 25 9g ml-'
drug treatment (C, n = 3). Cells were treated at 370C or combined with 430C
heating. Data shown are the mean ± s.e.m. Statistics (Student's t-test on
relative effects per experiment): *P< 0.05;**P < 0.025
24 h after removal ofcDDP, a higher fraction ofPt-DNA adducts
remained in the 60-min-heated EN cells than in the unheated cells
(P < 0.05). For the 60-min-heated ER cells as well as the 30-min-
heated EN and ER cells, a trend was observed showing that
relatively more damage was remaining than in the unheated cells
(Figure 2E), indicating a (small) effect ofheat on adduct removal.
Thermochemosensitization of GLC4 and GLC4-cDDP
cells
Figure 3 shows the thermal enhancement of cDDP sensitivity in
the human cell lines. GLC4 and GLC4-cDDP cells were equally
heat sensitive [30 min at 43°C, survival: GLC4 38.4% and GLC4-
cDDP 30.0% (NS); 60 min at 43°C, survival: GLC4 5.04% and
GLC4-cDDP 7.40% (NS)]. It is clear that extensive cDDP sensiti-
zation is caused by 43°C hyperthermia. TERs were 2.48 and 2.95
for 30- and 60-min heating, respectively, ofthe GLC4 cells. Forthe
resistant GLC4-cDDP cells, TERs of 2.10 and 5.85 were found,
resulting in a decrease ofthe resistance factor from 3.3 at 37°C to
1.5 in the 60-min-heated cells.
Heat effects (430C) on Pt accumulation and Pt-DNA
adduct formation in GLC4 and GLC4-cDDP cells
Figure 4 shows cellular Pt accumulation, total Pt-DNA adduct
formation and Pt-DNA adduct levels 6 and 24 h after cDDP incu-
bation in GLC4 and GLC4-cDDP cells when treated with cDDP at
37°C orcombined withhyperthermia. When the dataforGLC4 and
GLC4-cDDP treated at 37°C were compared, no significant differ-
ences between the two cell lines could be detected in the three
parameters.
Figure 4A shows that heating cells for 30 or 60 min at 43°C did
not significantly alter the cellular Pt accumulation in the GLC4
cells. The accumulation in the resistant cells, however, was
increased 1.44- and 2.09-fold (P < 0.05) for 30 and 60 min
heating, respectively, in cells treated with 50gg ml-1 (Figure 4A).
Performing a sign test on all individual accumulation data
irrespective of the concentration of cDDP used [i.e. also 5 and
10 jg ml-' (data not shown), 25 and 50 jg ml-' cDDP] showed no
significant effect ofheat on cDDP accumulation in the GLC4 cells
butdid reveal significant increases in Pt accumulation in the heated
GLC4-cDDP cells (P < 0.05). Hence, as observed for the EN/ER
cells, hyperthermia has a more pronounced effect on cellular Pt
accumulation in the resistant cells than in the sensitive cells.
Pt-DNA adduct formation immediately after cDDP treatment
was elevated in both heated GLC4 and GLC4-cDDP cells
compared with unheated cells (Figure 4B). In the cDDP-sensitive
GLC4 cells adduct formation was increased 1.7- to 2.4-fold when
combined with hyperthermia. For the cDDP-resistant subline,
significant increases in Pt-DNA adduct formation were found in
heated cells when the cells were treated with 25 ,ug ml-1 cDDP
(twofold increase, P < 0.05). The differences in cells treated with
50 ,ug ml1 cDDP were not significant. However, performing a sign
test on all individual Pt-DNA adduct data, irrespective of the
concentration of cDDP used (i.e. also 5 and 10 jg ml-' (data not
shown), 25 and 50jig ml-' cDDP), did reveal an effect ofboth heat
treatments on initial Pt-DNA adduct formation in the cDDP-resis-
tant cells (P < 0.05). In addition, Pt-DNA adduct formation in
GLC4 and GLC4-cDDP cells was measured using quantitative
immunocytochemistry (Meijer et al, 1995). Figure 5 shows typical
staining of GLC4 and GLC4-cDDP cells treated with 5 jig ml-'
cDDP for 4 h with or without a 60-min 430C heat treatment. The
results using this method again clearly indicate a heat-induced
increase in DNA platination. When all concentrations used (5, 10
and 25 jig ml-') were taken together, heat increased Pt-DNA
adduct formation by a factor of2.8 in GLC4 cells and by a factor of
1.72 in GLC4-cDDP cells. Hence, these results are similar to those
found in the EN/ER cells: heat increases initial Pt-DNA adduct
formation in both cDDP-sensitive and -resistant cells.
For Pt-DNA adduct levels remaining at 6 or 24 h after removal
of cDDP, no significant differences were observed for GLC4,
whereas for GLC4-cDDP a trend was observed showing that
60 min at 43°C increased the fraction of Pt-DNA adducts
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Figure 5 Immunocytochemical detection of Pt-DNA adduct formation in GLC4 and GLC4-cDDP cells treated with cDDP alone or combined with 430C heat.
Typical photographs ofGLC4 (A and C) and GLC4-cDDP (B and D) cells treated with 5 ,ug ml-' cDDP for 4 h at 370C (A and B) or combined with 60 min 430C
(C and D). Quantification of immunostaining of this typical experiment: (A) GLC4: 5 9g ml-' cDDP, no heat, 4.40; (B) GLC4-cDDP: 5 1lg ml-', no heat, 3.74;
(C) GLC4: 5 gg ml-' cDDP plus heat, 13.09; (D) GLC4-cDDP: 5 gg ml-' plus heat, 9.15
remaining in the DNA at 24 h (P =0.07) but not at 6 h after the end
ofthe incubation (Figure 4C).
Correlations between survival and cDDP-induced
damage (all cell lines)
Figure 6 shows the correlations between clonogenic survival after
treatment with 0.5 gg ml-' cDDP at 37°C or when combined with
43°C hyperthermia and the various parameters studied. Survival
after treatment with 0.5 jgml-1 was chosen as this was measurable
even in the most sensitive cells (EN cells heated for 60 min). As a
measure for cDDP-induced damage, the cellular Pt accumulation
and Pt-DNA adduct formation after treatment with 25 jg ml-'
cDDP were used, as this concentration was used for all parameters
studied. Although we realize that such a correlation between para-
meters measured at different concentration levels should be taken
with care, it is unavoidable because ofthe relative insensitivity of
the biochemical assays that are available. The data provided in
Figure 2 suggest that a linear relationship exists between the
various parameters and the concentration ofcDDP applied, both at
37°C and when combined with hyperthermia. Therefore, extra-
polation ofbiochemical measurements at this cDDP concentration
to concentrations relevant for cytotoxicity is assumed to be valid.
When all cell lines are taken into consideration, significant corre-
lations were found for all parameters. However, for Pt accumula-
tion (Figure 6A) and Pt-DNA adduct formation immediately after
treatment with cDDP (Figure 6B), r2-values were 0.59 and 0.64
respectively, indicating only weak correlations. The best correla-
tion between survival and cellular damage was found at 6 h after
cDDP treatment (Figure 6C); more than 95% of the variation in
survival could be related to the variation in absolute amount of
Pt-DNA adducts at this timepoint. At the 24-h timepoint (Figure
6D), the correlation was slightly weaker (r2 = 0.89).
DISCUSSION
In this study the mechanisms underlying cDDP sensitization by
hyperthermia in cDDP-resistant cells and their parent counterparts
were investigated at the level of drug accumulation, DNA adduct
formation and post-treatment adduct processing. Our data reveal
that the large overall effect of hyperthermia on cDDP sensitivity
may be explained by an accumulation of several different (small)
heat effects.
The resistance ofthe murine (ER) cells seems for a large part to
be due to decreased drug accumulation and adduct formation.
Neither initial total DNAplatination norinitial bifunctional adduct
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Figure 6 Correlation plots of survival after cDDP treatment vs cDDP damage Correlation plots of survival of EN, ER, GLC4 and GLC4-cDDP cells after
treatment with 0.5 jg ml-' cDDP at 370C or combined with 430C hyperthermia vs the various biochemical parameters studied. Plotted are the cellular Pt
accumulation after treatment with 25 ig ml-' cDDP (A), the Pt-DNA adduct formation after treatment with 25 ig ml-' cDDP (B), the Pt-DNA adduct levels at 6 h
after the end of a 25 ig ml-' drug treatment (C) and the Pt-DNA adduct levels at 24 h after the end of a 25 9g ml-' drug treatment (D)
formation (as determined by immunocytochemistry) were signifi-
cantly lowered in the resistant GLC4-cDDP cells, in contrast to
what was found previously in other resistant sublines derived from
the GLC4 cells (Hospers et al, 1988, 1990; Meijer et al, 1990).
Individual adducts, however, could differ between the cell lines.
Cellular GSH may influence adduct formation, e.g. by quenching
the conversion of mono- into (specific) bifunctional adducts
(Micetich et al, 1983; Eastman, 1987). As we found significantly
higher GSH levels in the cDDP-resistant subline (data not shown),
this therefore may have altered the kinetics of formation and
removal, as well as the spectrum of bifunctional adducts formed,
and by this led to resistance.
Several studies using rodent cell lines have indicated that an
important effect of heating cells during or before cDDP treatment
is increased accumulation of the drug (Wallner et al, 1986;
Mansouri et al, 1989; Eichholtz-Wirth and Hietel, 1990; Los et al,
1993; Takahashi et al, 1993; Ohno et al, 1994). This however was
not always found to be the case (Herman et al, 1990) or was found
to be true for relatively high heat doses only (Takahashi et al,
1993). The present study indicates that in the murine cDDP-sensi-
tive and -resistant EN and ER cells 43°C heat did increase accu-
mulation of cDDP, although the effect was only marginal in the
EN cells. Only two studies using human cell lines have been
published so far, reporting either increased drug accumulation for
treatment at 40°C (Mann et al, 1988) or no effect of increasing
treatment temperature up to 45°C on Pt accumulation in either
cDDP-sensitive or -resistant cells (Herman et al, 1988). We found
that heat causes no increased Pt accumulation in the cDDP-
sensitive GLC4 cells, whereas the Pt accumulation was increased
in the resistant subline.
Interestingly, in both sets of cell lines studied here, the effect of
43°C heating on cellular Pt accumulation was higher in the resis-
tant cell lines. In all cases published in which an effect of heat on
cDDP accumulation was noticed, the same trend of a (slightly)
higher effect of heat on drug accumulation in the cDDP-resistant
cells can be observed (Wallner et al, 1986; Mann et al, 1988;
Mansouri et al, 1989). One of the major mechanisms ofresistance
in all these cell lines, as well as in the ER cells (this study), was
decreased drug accumulation, thereby indicating that the factor
causing the accumulation defect in the resistant cells is sensitive to
modulation by hyperthermia. The mechanism by which cDDP
enters cells and the alteration that causes decreased accumulation
in resistant cells is still unknown. The model proposed by Gately
and Howell (1993) that accumulation may occur for approximately
50% by passive diffusion and for 50% by facilitated diffusion
through a gated channel can account for most experimental data.
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The latter part seems more likely to be altered in resistant cells and
so it can be speculated that differences in membrane proteins
causing either decreased drug uptake or increased drug efflux
could also cause differences in heat sensitivity ofcDDP accumula-
tion. Whether this is the case remains to be elucidated.
So, a hyperthermic effect on accumulation is often found. This
is however not always the case and its mechanism is unclear.
Moreover, enhancement of cDDP toxicity by heating after drug
exposure has been shown to be possible in some cell lines and
tumours (Fisher and Hahn, 1982; Baba et al, 1989; Urano et al,
1990), indicating that hyperthermia must have other effects that
can contribute to cDDP sensitization (see below).
Under all conditions studied, it was found that heat increased
the levels of Pt-DNA adducts formed immediately after the drug
treatment. The few studies that have measured total DNA platina-
tion in heated cells also reported increased overall Pt-DNA adduct
levels (Los et al, 1993; Ohno et al, 1994). In our study, this was
true also for the cDDP-sensitive cells that showed only minor heat
effects on drug accumulation. Theoretically, the latter could be due
to a hyperthermia-induced decrease in GSH levels reducing the
ability ofthe cell to detoxify cDDP before reacting with the DNA.
However, heating at 43°C decreased GSH levels in the murine
cells by only 15% (ER) and 25% (EN) and did not affect GSH
levels in the human cells at all (data not shown). Also, heat may
have increased the reactivity ofcDDP with DNA. In vitro incuba-
tion ofplasmid DNA with cDDP revealed increased reaction rates
at 42°C compared with 37°C (Herman et al, 1989), whereas the
reaction ofcDDP with salmon sperm DNA in solution showed no
temperature dependency (Los et al, 1993). Both experiments,
however, do not take into account the complex structure of DNA
in the eukaryotic nucleus. This is, of course, most relevant when
treating intact cells, and is especially important as it has been
shown that hyperthermia causes dramatic changes in chromatin
structure (Laszlo, 1992; Kampinga, 1993) that may influence Pt
binding to the DNA.
Heat effects on Pt-DNA damage induction in cDDP-resistant
cells have not been studied before. In the present study, however,
no difference was found between sensitive and resistant cells, indi-
cating that the mechanisms of cDDP-resistance do not interfere
with heat effects on adduct formation. In any case, it is clear that
hyperthermic potentiation of cDDP toxicity is also, in part, due to
elevated levels of initial DNA damage.
As hyperthermia is known to be able to inhibit repair of DNA
damage induced by other means [e.g. ionizing radiation (Konings
1987) and UV irradiation (Sakkers et al, 1993)], we also studied
the removal ofPt-DNA adducts. The percentage adducts removed
was not always found to be significantly decreased in the heated
cells. Yet, in all cell lines studied here, a trend was observed that
more damage was remaining in the DNA ofthe heated cells.
Studies on repair ofPt-DNA damage are always complicated by
the fact that, after the end of a drug exposure, still additional
adducts are formed during the removal of others. Moreover, heat-
inducedinhibition ofrepair ofDNA damage is to be expected to last
foronly a few hours. Cells recover within a few hours from the heat
damage causing repair inhibition (most likely heat-induced protein
aggregation; Konings 1992; Sakkers et al, 1993; Stege et al, 1995).
After this time period, repair resumes at normal rates (Sakkers et al,
1993, 1995a and b). Meyn et al (1980) studied kinetics of inter-
strand cross-link (ISCL) formation and removal in unheated and
43°C-heated Chinese hamster ovary cells. Their data show that the
post-incubation increase in ISCL seems to be elevated and
prolonged in heated cells, suggesting that the balance between
formation and removal of cross-links is altered as a result of (tran-
sient) inhibition of DNA repair. Our data for total DNA platination
are suggestive of a similar effect; in the EN and GLC4 cells, in
particular, high total DNA platination levels were found at 6 h after
incubation in the 60-min-heated cells. In a recent publication by
Ohno et al (1994), no effect of heating on the kinetics of ISCL
formation in murine L1210 cells was seen; however the temperature
used in this study (41.5°C) may have been too low, as such temper-
ature treatments generally do not cause significant nuclear protein
aggregation (unpublished data) and repair inhibition of, e.g. radia-
tion-induced strand breaks (Dikomey, 1982). Yet, in another study
(Los et al, 1993) no effect ofheat (43°C) on the kinetics of total Pt-
adduct formation and removal was seen. They, however, used a
different immunocytochemical method to assay for DNA platina-
tion and two different concentrations of cDDP for heated and
unheated cells, impairing a direct comparison between their data
and ours. Yet again, besides altered drug accumulation and adduct
formation, altered adduct processing (repair) may also contribute to
enhanced cDDP lethality under hyperthermic conditions.
In conclusion, like the mechanisms of resistance to cDDP, the
effects of hyperthermia on cDDP action seem to be multifactorial.
Heat was shown to have some effect on all the parameters studied. A
strong argument in favour of the multifactorial effects of hyper-
thermia are the results shown in Figure 6; the best correlations are
found with the Pt-DNA adduct levels at 6 and 24 h after exposure to
the drug. These parameters reflect not only heat effects on Pt accu-
mulation and initial Pt-DNA adduct formation but also on the
kinetics of Pt-DNA adduct formation and removal. So, although the
effect ofhyperthermia on some of these individual parameters may
not be very large, the combined effect may account for the large
potentiation ofcDDP action that heat causes. This also explains why
single-parameter analyses, as performed in the past, have been
inconclusive so far. We have shown that these pleiotropic effects of
heat are also effective in enhancing cDDP accumulation, adduct
formation and/or adduct removal in cDDP-resistant cells. This indi-
cates why the multifactorial aspects of hyperthermia have been
found to be so suitable for the (partial) reversal of cDDP resistance
in a variety of cell lines with different mechanisms of resistance
(Wallner et al, 1986; Herman et al, 1988; Mansouri et al, 1989;
Konings et al, 1993; Hettinga et al, 1994; this study). Therefore, our
data provide a scientific basis for supporting the use of combined
heat and cDDP chemotherapy in cDDP-resistant tumours, and there-
fore this combined modality deserves further attention in the clinic.
ABBREVIATIONS
cDDP, cis-diamminedichloroplatinum(II), cisplatin; Pt, platinum;
FITC, fluorescein isothiocyanate; RPMI-1640, Roswell Park
Memorial Institute medium 1640; PBS, phosphate-buffered saline
(1.5 mm potassium dihydrogen phosphate, 6.5 mm disodium
hydrogen phosphate, 137 mm sodium chloride, 2.7 mm potassium
chloride, pH 7.4); FAAS, flameless atomic absorption spectrometry;
ISCL, interstrand cross-links; TER, thermal enhancement ratio -
ratio between the cisplatin concentration needed to kill 90% of the
cells at 37'C andtheconcentration ofcisplatin needed to kill 90% of
the cells when combined with heat treatment; GSH, glutathione.
ACKNOWLEDGEMENTS
The authors wish to thank Edwin Modderman, Geurt Wolsink and
Francien Lode for technical assistance in isolating DNA from
British Journal ofCancer (1997) 75(12), 1735-1743 0 CancerResearch Campaign 1997Mechanism ofinteraction between heatand cDDP 1743
cDDP-treated cells. Jan Ymker and Dries Groefsema (Hospital
Pharmacy of the University Hospital Groningen) are gratefully
acknowledged for skilful Pt measurements. The authors thank
WJ Sluiter PhD for expert help with statistical analysis of the
data. This study was financially supported by grant GUKC 91-09
ofthe Dutch Cancer Society.
REFERENCES
Andrews PA and Howell SB (1990) Cellular pharmacology ofcisplatin: perspectives
on mechanisms ofacquired resistance. Cancer Cells 2: 35-43
Baba H, Siddik ZH, Strebel FR, Jenkins GN and Bull JMC (1989) Increased
therapeutic gain ofcombined cis-diamminedichloroplatinum(II) and whole
body hyperthermia therapy by optimal heat/drug scheduling. Cancer Res 49:
7041-7044
Dikomey E (1982) Effect ofhyperthermia at 42°C and 45°C on repair ofradiation-
induced DNA strand breaks in CHO cells. Int J RadBiol 41: 603-614
Eastman A (1987) Cross-linking ofglutathione to DNA by cancer chemotherapeutic
platinum coordination complexes. Chem Biol Interactions 61: 241-248
Eichholtz-Wirth H and Hietel B (1990) Heat sensitization to cisplatin in two cell
lines with different drug sensitivities. IntJHyperthermia 6: 47-55
Engelhardt R (1987) Hyperthermia and drugs. Recent Results in Cancer Res 104:
136-203
Fichtinger-Schepman AMJ, Van Oosterom AT, Lohman PHM and Berends F (1987)
Cis-diamminedichloroplatinum(II)-induced DNA adducts in peripheral
leukocytes from seven cancer patients: quantitative immunochemical detection
ofthe adduct induction and removal after a single dose ofcis-
diamminedichloroplatinum(1l). Cancer Res 47: 3000-3004
Fisher GH and Hahn GM (1982) Enhancement ofcis-platinum(II)
diamminedichloride cytotoxicity by hyperthermia. NatI Cancer Inst
Monographs 61: 255-257
Gately D and Howell SB (1993) Cellular accumulation ofthe anticancer agent
cisplatin: a review. Br J Cancer 67: 1171-1176
Herman TS, Teicher BA, Cathcart KNS, Kaufmann ME, Lee JB and Lee M-H
(1988) Effect ofhyperthermia on cis-diamminedichloroplatinum(II) and
(Rhodamine 123)2 [tetrachloro-platinum(II)] in a human squamous cell
carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.
Cancer Res 48: 5101-5105
Herman TS, Teicher BA, Chan V, Collins LS and Abrams MJ (1989) Effect ofheat
on the cytotoxicity and interaction with DNA of a series ofplatinum
complexes. Int JRad Oncol Biol Phys 16: 443-449
Herman TS, Teicher BA, Pfeffer MR, Khandekar VS and Korbut TT (1990)
Interaction with hyperthermia oftetrachloroplatinum(lI)(Nile Blue), and
tetrachloroplatinum(II)(Neutral Red)2 in EMT6 murine cells and the murine
FSaIIC fibrosarcoma. Cancer Res 50: 3826-3831
Hettinga JVE, Lemstra W, Meijer C, Mulder NH, Konings AWT, De Vries EGE and
Kampinga HH (1994) Hyperthermic potentiation ofcisplatin toxicity in a
human small cell lung carcinoma cell line and a cisplatin resistant subline. IntJ
Hyperthermia 10: 795-805
Hospers GAP, Mulder NH, De Jong B, De Ley L, Uges DRA, Fichtinger-Schepman
AMJ, Scheper RJ and De Vries EGE (1988) Characterization of a human small
cell lung carcinoma cell line with acquired cisplatin resistance in vitro. Cancer
Res 48: 6803-6807
Hospers GAP, Meijer C, De Leij L, Uges DRA, Mulder NH and De Vries EGE
(1990) A study on human small cell lung carcinoma (hSCLC) cell lines with
different sensitivities to detect relevant mechanisms ofcisplatin (cDDP)
resistance. IntJ Cancer 46: 138-144
Kampinga HH (1993) Thermotolerance in mammalian cells. Protein denaturation
and aggregation, and stress proteins. J Cell Science 104: 11-17
Konings AWT (1987) Effects ofheat and radiation on mammalian cells. Radiat Phys
Chem 30: 339-349
Konings AWT (1992) Thermal radiosensitization: role ofheat shock proteins in heat-
induced alterations ofprotein conformation. In Proceedings ofthe 6th Int.
Congress on Hyperthermic Oncol., Gemer EW (ed.), pp. 109-113. Arizona
Board of Regents: Tucson, AZ, USA
Konings AWT, Hettinga JVE, Lemstra W, Humphrey GB and Kampinga HH (1993)
Sensitizing for cis-diamminedichloroplatinum(II) action by hyperthermia in
resistant cells. IntJ Hyperthermia 9: 553-562
Laszlo A (1992) The thermoresistant state: protection from initial damage or better
repair? Exp Cell Res 202: 519-531
Los G, Van Vugt MJH, Den Engelse L and Pinedo HM (1993) Effects oftemperature
on the interaction ofcisplatin and carboplatin with cellular DNA. Biochem
Pharmacol 46: 1229-1237
Mann SC, Andrews PA and Howell SB (1988) Comparison oflipid content, surface
membrane fluidity, and temperature dependence ofcis-
diamminedichloroplatinum(II) accumulation in sensitive and resistant human
ovarian carcinoma cells. Anticancer Res 8: 1211-1216
Mansouri A, Henle KJ, Benson AM, Moss AJ and Nagle WA (1989)
Characterization of a cisplatin-resistant subline of murine Rif-1 cells and
reversal ofdrug resistance by hyperthermia. Cancer Res 49: 2674-2678
Meijer C, Mulder NH, Hospers GAP, Uges DRA and De Vries EGE (1990) The role
ofglutathione in resistance to cisplatin in a human small cell lung cancer cell
line. Br J Cancer 62: 72-77
Meijer C, De Vries EGE, Dam WA, Wilkinson MHF and Mulder NH (1995)
Immunocytochemical detection ofDNA-platination in human tissue using a
polyclonal antibody: feasibility ofpredictive testing. Proc Am Assoc Cancer
Res 36: 2377
Meyn RE, Corry PM, Fletcher SE and Demetriades M (1980) Thermal enhancement
of DNA damage in mammalian cells treated with cis-
diamminedichloroplatinum(II). Cancer Res 40: 1136-1139
Micetich K, Zwelling LA and Kohn KW (1983) Quenching ofDNA-platinum(II)
monoadducts as a possible mechanism ofresistance to cis-
diamminedichloroplatinum(II) in L1210 cells. Cancer Res 43: 3609-3613
Ohno S, Siddik ZH, Kido Y, Zwelling LA and Bull JMC (1994) Thermal
enhancement ofdrug uptake and DNA adducts as a possible mechanism for the
effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210
cells. Cancer Chemother Pharmacol 34: 302-306
Sakkers RJ, Filon AR, Brunsting JF, Kampinga HH, Mullenders LHF and Konings
AWT (1993) Heat-shock treatment selectively affects induction and repair of
cyclobutane pyrimidine dimers in transcriptionally active genes in ultraviolet-
irradiated human fibroblasts. Radiat Res, 135: 343-350
Sakkers RJ, Filon AR, Kampinga HH, Konings AWT and Mullenders LH (1995a)
Repair ofUV-induced pyrimidine(6-4)pyrimidone photoproducts is selectively
inhibited in transcriptionally active genes after heat treatment ofhuman
fibroblast. IntJRadiat Biol 67: 495-499
Sakkers RJ, Filon AR, Brunsting JF, Kampinga HH, Konings AWT and Mullenders
LH (1995b) Selective inhibition ofrepair ofactive genes by hyperthermia is
due to inhibition ofglobal and transcription coupled repair pathways.
Carcinogenesis 16: 743-748
Stege GJJ, Kampinga HH and Konings AWT (1995) Heat-induced intranuclear
protein aggregation and thermal radiosensitization. Int JRadiat Biol 67:
203-209
Takahashi I, Maehara Y, Kusumoto H, Kohnoe S and Sugimachi K (1993) Heat
enhances the cytotoxicity ofcis-diamminedichloroplatinum(II) and its
analogues cis-1,I-cyclobutane-dicarboxylato(2R)-2-methyl- 1,4-
butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
Cancer Chemother Pharmacol 33: 31-35
Urano M, Kahn J and Kenton LA (1990) The effect ofcis-
diamminedichloroplatinum(II) treatment at elevated temperatures on murine
fibrosarcoma, FSa-II. IntJHyperthermia 6: 563-570
Wallner KE, Degregorio MW and Li GC (1986) Hyperthermic potentiation ofcis-
diamminedichloroplatinum(II) cytotoxicity in chinese hamster ovary cells
resistant to the drug. Cancer Res 46: 6242-6245
C Cancer Research Campaign 1997 British Journal ofCancer (1997) 75(12), 1735-1743